Resolv announced today that it has closed a $500,000 pre-seed funding round to accelerate development of its crypto asset recovery infrastructure. The round wasResolv announced today that it has closed a $500,000 pre-seed funding round to accelerate development of its crypto asset recovery infrastructure. The round was

RESOLV SECURES $500,000 PRE-SEED TO BUILD THE RECOVERY LAYER FOR STOLEN CRYPTO

Resolv announced today that it has closed a $500,000 pre-seed funding round to accelerate development of its crypto asset recovery infrastructure. The round was led by Funfair Ventures and includes participation from the University of Illinois, University of Chicago, OCA Ventures, Orange DAO, Quantstamp, Kyber Network and WBTC.

The core thesis is simple: in traditional finance, theft recovery is guaranteed. In crypto, it’s been treated as impossible. Resolv changes that by enabling users and protocols to recover stolen ERC-20 tokens through a decentralized arbitration system—something the industry has never had before.

“Since crypto’s inception, the playbook has been binary: either you trust a centralized custodian or you shoulder all the risk yourself,” said Will Lawson, CEO and founder of Resolv. “We’re introducing a third option. Resolv puts stolen crypto back in your wallet through a transparent, decentralized process. No central gatekeeper. No victim blaming.”

The protocol works through a five-step mechanism:

  • wrap your assets into protected tokens (pTokens)
  • report theft if it occurs
  • a freeze algorithm is triggered that locks stolen assets across the chain
  • then a decentralized panel of forensic experts (jurors) review the evidence
  • and recover your funds if the claim is validated.

The entire process happens on-chain, with no centralized authority able to unilaterally approve or deny recovery.
This approach solves a problem that has plagued crypto since its inception. Over $20 billion in crypto has been stolen since 2011, with no mechanism for recovery. Victims are left with nothing but the industry’s cold refrain: “Not your keys, not your crypto.” Resolv rejects that fatalism.

Demand is real. Resolv’s mainnet MVP is currently in closed beta, with 2,000 users committed to protecting $140 million in assets—a metric that reflects genuine market demand rather than speculative interest. Each user on the waitlist represents an organization or individual who recognizes that crypto needs a recovery layer to scale beyond early adopters.

Resolv is allocating the pre-seed capital primarily toward team expansion, with resources dedicated to deepening the core recovery infrastructure, scaling user and business development, establishing regulatory foundations, and operational growth.

The protocol’s innovation lies in its decentralized arbitration model. Rather than relying on a centralized authority, Resolv uses a rotating panel of on-chain forensic investigators (in the future, drawn from firms like Chainalysis, independent security researchers, and insurance partners) who are randomly selected for each case using verifiable randomness. These jurors review theft claims, analyze transaction history, and vote on whether recovery should be approved. A majority threshold (2 of 3) triggers automated recovery. No single party—not Resolv, not the user, not any individual juror—can unilaterally authorize recovery.

This design preserves Resolv’s core principle: recovery happens only when the chain of events is transparent and agreed upon by the network.
With mainnet now live and organizations queueing for integration, Resolv is positioned to become the default recovery layer for crypto assets. As institutional capital continues flowing on-chain, the demand for fraud protection mechanisms will only accelerate. The question is no longer whether crypto needs recovery—it’s when it will be available.

“This pre-seed validates something we knew from day one,” Lawson added. “The crypto industry isn’t asking whether it needs a recovery layer. It’s asking when it’ll be ready.”

More information about Resolv is available at resolv.finance.

About Resolv

Resolv puts stolen crypto back in your wallet. The protocol enables users and organizations to recover stolen ERC-20 tokens through a decentralized arbitration system backed by on-chain forensic experts. Resolv uses recoverable wrapped tokens know as “protected tokens” (pTokens) and a freeze algorithm to intercept stolen assets. Recovery decisions are made by jurors selected randomly from a vetted pool of blockchain forensics professionals. Founded in 2023, Resolv has attracted 2,000 users to their waitlist, eager to protect $140 million in assets. The mainnet MVP is currently in closed beta.

Market Opportunity
SEED Logo
SEED Price(SEED)
$0.0004888
$0.0004888$0.0004888
+0.16%
USD
SEED (SEED) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26